Fractures in women treated with raloxifene or alendronate: a retrospective database analysis (Q34632451)

3 August 2017

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis (English)

1 reference

3 August 2017

0 references

Shonda A Foster

1

1 reference

3 August 2017

Nianwen Shi

2

1 reference

3 August 2017

Suellen Curkendall

3

1 reference

3 August 2017

John Stock

4

1 reference

3 August 2017

Bong-Chul Chu

5

1 reference

3 August 2017

Russel Burge

6

1 reference

3 August 2017

David R Diakun

7

1 reference

3 August 2017

John H Krege

8

1 reference

3 August 2017

23 March 2013

1 reference

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

15

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

start time

23 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1472-6874-13-15

0 references

cites work

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

"Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Effectiveness of bisphosphonate therapy in a community setting

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

FRAX and the assessment of fracture probability in men and women from the UK

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

The worldwide problem of osteoporosis: insights afforded by epidemiology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-13-15

Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-13-15

A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-13-15

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-13-15

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626542

Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23521803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23521803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23521803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Deservingness to state health services for South-South migrants: a preliminary study of Costa Rican providers' views

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.SOCSCIMED.2011.06.045

Identifiers

DOI

10.1186/1472-6874-13-15

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference